In patients with symptomatic heart failure, sacubitril–valsartan has been found to reduce the risk of hospitalization and death from cardiovascular causes more effectively than an ...
Advanced CKD in AMI patients receiving MCS is associated with increased mortality, complications, and resource utilization compared to those without advanced CKD. ESRD patients undergoing CABG after ...